Skip to content
Menu

Amneal Pharmaceuticals, Inc. AMRX

Full chart Compare
Set alert

Price alert · AMRX

All alert types
21.12 USD -0.27 (-1.26%)

Regular-session close

21.78 +0.66 +3.15%

After hours · Nov 20, 6:11 PM ET

21.07 Day range 21.70
11.52 52-week range 21.88
YTD
+67.62%
1 year
+83.33%

Revenue & Expenses

Revenue Profit Costs
Gross Profit$1.14BCost of Revenue$1.88BNet Income$72.06MSelling, General & Admin$526.83MResearch & Development$186.18MInterest Expense$241.09MOther Expenses$98.67MIncome Tax$11.28MRevenue$3.02B

Latest period ending Dec 31, 2025 · select a line to chart its full history

AMRX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
3.02B2.79B2.39B2.21B2.09B
1.11B1.02B820.57M784.71M768.97M
394.10M249.33M204.37M-94.20M152.92M
72.06M-116.89M-83.99M-129.99M10.62M
0.22-0.38-0.48-0.860.07
AMRX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
310.87M118.42M99.11M35.23M256.74M
3.68B3.50B3.47B3.80B3.94B
3.75B3.61B3.45B3.62B3.57B
2.69B2.59B2.75B2.85B2.88B
-70.79M-109.27M19.78M298.42M360.34M
AMRX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
339.99M295.10M345.58M65.10M241.82M
-112.26M-63.00M-69.19M-174.31M-194.18M
-31.53M-211.79M-212.57M-106.62M-138.12M
-96.75M-60.34M-46.80M-48.80M-50.94M
194.52M19.31M63.88M-221.51M-90.38M